Resolved -
This incident has been resolved.
Jul 27, 08:51 EDT
Update -
Ongoing monitoring is reflecting stability in ACK processing we are continuing to monitor.
Jul 24, 11:28 EDT
Update -
Ongoing monitoring is reflecting stability in ACK processing we are continuing to monitor.
Jul 23, 19:42 EDT
Update -
Ongoing monitoring is reflecting stability in ACK processing we are continuing to monitor.
Additionally, the FDA has informed us that ACK3 messages will have a delayed responses until July 27.
Jul 23, 15:19 EDT
Monitoring -
Ongoing monitoring is reflecting stability in ACK processing we are continuing to monitor.
Additionally, the FDA has informed us that ACK3 messages will have a delayed responses until July 27.
Jul 23, 12:33 EDT
Identified -
We are currently experiencing delays in ACK processing, which is impacting the normal processing rate. Our team is actively monitoring the situation and will continue to provide regular status updates.
Additionally, the FDA has informed us that ACK3 messages will not be received until July 27. We are monitoring this dependency and will share updates as they become available.
Jul 23, 10:36 EDT